Premenopausal Breast Cancer: Estrogen Receptor Status and Insulin-Like Growth Factor-I (IGF-I), Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3), and Leptin
✍ Scribed by Jennifer Eng-Wong; Susan N. Perkins; Melissa Bondy; Donghui Li; Sonya Eva Singletary; Nomelí Núñez; Stephen Hursting; Shine Chang
- Book ID
- 109079838
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 46 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1075-122X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) play an important role in cell growth and differentiation. Clinical and epidemiological studies have indicated that measuring IGFs and IGFBPs in blood has potential implications in assessing growth-related abnormalities and risks o
Insulin-like growth factors (IGFs) are potent mitogens involved in the regulation of cell proliferation and apoptosis. The action of IGFs is mediated through a specific cell membrane receptor (IGF-IR), and the interactions between IGFs and this receptor are regulated by IGF-binding proteins (IGFBPs)
## Studies have demonstrated the presence of epidermal growth factor receptors in human parathyroid tumors. However, there is little information on the effect of other peptide growth factors on parathyroid cell growth. We therefore studied the interaction of insulin-like growth factor I (IGF-I) wi
## Abstract Recent epidemiological studies have shown that high serum levels of insulin‐like growth factor‐I (IGF‐I) are associated with an increased risk of lung, colon, breast and prostate cancer. Since very few studies have addressed the role of serum levels of IGF‐I in the development of pancre